Compare BTOG & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTOG | SBFM |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.3M |
| IPO Year | 2018 | 2008 |
| Metric | BTOG | SBFM |
|---|---|---|
| Price | $0.81 | $1.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 194.9K | ★ 422.8K |
| Earning Date | 06-26-2026 | 04-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,305,891.00 |
| Revenue This Year | N/A | $40.47 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $0.08 | $0.25 |
| 52 Week High | $5.96 | $3.05 |
| Indicator | BTOG | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 36.86 | 32.50 |
| Support Level | $0.62 | $1.13 |
| Resistance Level | $0.94 | $1.28 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 66.66 | 17.02 |
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions. It derives all of its revenue from Bitcoin mining.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.